Teladoc Health, Inc. (NYSE:TDOC) Stock Position Increased by ARK Investment Management LLC

ARK Investment Management LLC raised its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 4.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,224,565 shares of the health services provider's stock after purchasing an additional 912,692 shares during the quarter. Teladoc Health accounts for approximately 2.7% of ARK Investment Management LLC's investment portfolio, making the stock its 12th largest holding. ARK Investment Management LLC owned approximately 12.82% of Teladoc Health worth $457,389,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. MetLife Investment Management LLC purchased a new stake in shares of Teladoc Health in the first quarter valued at approximately $218,000. Panagora Asset Management Inc. grew its position in shares of Teladoc Health by 18.8% during the 1st quarter. Panagora Asset Management Inc. now owns 16,710 shares of the health services provider's stock worth $1,205,000 after buying an additional 2,640 shares in the last quarter. Rhumbline Advisers grew its position in shares of Teladoc Health by 2.3% during the 1st quarter. Rhumbline Advisers now owns 130,916 shares of the health services provider's stock worth $9,443,000 after buying an additional 2,921 shares in the last quarter. Great West Life Assurance Co. Can raised its holdings in shares of Teladoc Health by 10.8% in the first quarter. Great West Life Assurance Co. Can now owns 107,908 shares of the health services provider's stock valued at $8,237,000 after acquiring an additional 10,559 shares in the last quarter. Finally, Raymond James Trust N.A. lifted its stake in Teladoc Health by 7.8% in the first quarter. Raymond James Trust N.A. now owns 11,451 shares of the health services provider's stock worth $826,000 after acquiring an additional 827 shares during the period. 76.82% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, insider Arnnon Geshuri sold 7,500 shares of Teladoc Health stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $15.06, for a total value of $112,950.00. Following the sale, the insider now directly owns 38,470 shares in the company, valued at approximately $579,358.20. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, CTO Nikolaos P. Nanis sold 2,866 shares of the company's stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $41,614.32. Following the completion of the sale, the chief technology officer now owns 69,850 shares of the company's stock, valued at $1,014,222. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Arnnon Geshuri sold 7,500 shares of the firm's stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $15.06, for a total transaction of $112,950.00. Following the completion of the transaction, the insider now directly owns 38,470 shares in the company, valued at $579,358.20. The disclosure for this sale can be found here. Insiders sold a total of 134,441 shares of company stock worth $2,025,041 in the last 90 days. Insiders own 1.63% of the company's stock.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Cantor Fitzgerald assumed coverage on shares of Teladoc Health in a research report on Thursday, February 29th. They set an "overweight" rating and a $22.00 target price on the stock. Citigroup reduced their price objective on shares of Teladoc Health from $21.00 to $19.00 and set a "neutral" rating for the company in a research note on Wednesday, February 21st. Canaccord Genuity Group dropped their target price on Teladoc Health from $34.00 to $28.00 and set a "buy" rating on the stock in a research report on Wednesday, February 21st. SVB Leerink initiated coverage on Teladoc Health in a research report on Monday, February 26th. They issued a "market perform" rating and a $17.00 price target for the company. Finally, DA Davidson reduced their target price on shares of Teladoc Health from $22.00 to $18.00 and set a "neutral" rating for the company in a report on Wednesday, February 21st. Eight analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $22.43.

Teladoc Health Stock Performance

Shares of NYSE TDOC traded down $0.17 during midday trading on Thursday, reaching $15.10. 2,478,536 shares of the stock were exchanged, compared to its average volume of 4,668,144. The company has a quick ratio of 3.47, a current ratio of 3.54 and a debt-to-equity ratio of 0.66. The firm has a 50-day simple moving average of $17.60 and a two-hundred day simple moving average of $18.60. Teladoc Health, Inc. has a twelve month low of $14.29 and a twelve month high of $30.41. The firm has a market cap of $2.52 billion, a price-to-earnings ratio of -11.40 and a beta of 0.94.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings data on Tuesday, February 20th. The health services provider reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.05. The company had revenue of $660.50 million for the quarter, compared to analyst estimates of $670.79 million. Teladoc Health had a negative return on equity of 9.22% and a negative net margin of 8.47%. Teladoc Health's quarterly revenue was up 3.6% compared to the same quarter last year. During the same period last year, the company earned ($0.23) earnings per share. As a group, analysts anticipate that Teladoc Health, Inc. will post -1.07 EPS for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.